Diane Smith1, Ross Wilkie1, Peter Croft1, John McBeth2. 1. Arthritis Research UK Primary Care Centre, Research Institute for Primary Care and Health Sciences, Keele University, Staffordshire, UK. 2. Arthritis Research UK Centre for Epidemiology, and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
Abstract
OBJECTIVE: Moderate to severe chronic pain affects 1 in 5 adults. Pain may increase the risk of mortality, but the relationship is unclear. This study investigated whether mortality risk was influenced by pain phenotype, characterized by pain extent or pain impact on daily life. METHODS: The study population was drawn from 2 large population cohorts of adults ages ≥50 years, the English Longitudinal Study of Ageing (n = 6,324) and the North Staffordshire Osteoarthritis Project (n = 10,985). Survival analyses (Cox's proportional hazard models) estimated the risk of mortality in participants reporting any pain and then separately according to the extent of pain (total number of pain sites, widespread pain according to the American College of Rheumatology [ACR] criteria, and widespread pain according to Manchester criteria) and pain impact on daily life (pain interference and often troubled with pain). Models were cumulatively adjusted for age, sex, education, and wealth/adequacy of income. RESULTS: After adjustments, the report of any pain (mortality rate ratio [MRR] 1.06 [95% confidence interval (95% CI) 0.95-1.19]) or having widespread pain (ACR 1.07 [95% CI 0.92-1.23] or Manchester 1.16 [95% CI 0.99-1.36]) was not associated with an increased risk of mortality. Participants who were often troubled with pain (MRR 1.29 [95% CI 1.12-1.49]) and those who reported quite a bit of pain interference (MRR 1.38 [95% CI 1.20-1.59]) and extreme pain interference (MRR 1.88 [1.54-2.29]) had an increased risk of all-cause mortality. CONCLUSION: Pain that interferes with daily life, rather than pain per se, was associated with an increased risk of mortality. Future studies should investigate the mechanisms through which pain increases mortality risk.
OBJECTIVE: Moderate to severe chronic pain affects 1 in 5 adults. Pain may increase the risk of mortality, but the relationship is unclear. This study investigated whether mortality risk was influenced by pain phenotype, characterized by pain extent or pain impact on daily life. METHODS: The study population was drawn from 2 large population cohorts of adults ages ≥50 years, the English Longitudinal Study of Ageing (n = 6,324) and the North Staffordshire Osteoarthritis Project (n = 10,985). Survival analyses (Cox's proportional hazard models) estimated the risk of mortality in participants reporting any pain and then separately according to the extent of pain (total number of pain sites, widespread pain according to the American College of Rheumatology [ACR] criteria, and widespread pain according to Manchester criteria) and pain impact on daily life (pain interference and often troubled with pain). Models were cumulatively adjusted for age, sex, education, and wealth/adequacy of income. RESULTS: After adjustments, the report of any pain (mortality rate ratio [MRR] 1.06 [95% confidence interval (95% CI) 0.95-1.19]) or having widespread pain (ACR 1.07 [95% CI 0.92-1.23] or Manchester 1.16 [95% CI 0.99-1.36]) was not associated with an increased risk of mortality. Participants who were often troubled with pain (MRR 1.29 [95% CI 1.12-1.49]) and those who reported quite a bit of pain interference (MRR 1.38 [95% CI 1.20-1.59]) and extreme pain interference (MRR 1.88 [1.54-2.29]) had an increased risk of all-cause mortality. CONCLUSION: Pain that interferes with daily life, rather than pain per se, was associated with an increased risk of mortality. Future studies should investigate the mechanisms through which pain increases mortality risk.
Authors: Galit Levi Dunietz; Leslie M Swanson; Erica C Jansen; Ronald D Chervin; Louise M O'Brien; Lynda D Lisabeth; Tiffany J Braley Journal: Sleep Date: 2018-09-01 Impact factor: 5.849
Authors: William C Becker; Michael J Fischer; Daniel G Tobin; Mark B Lockwood; Paul L Kimmel; Laura M Dember; Nwamaka D Eneanya; Manisha Jhamb; Thomas D Nolin Journal: Nat Rev Nephrol Date: 2021-10-07 Impact factor: 28.314
Authors: Jinjiao Wang; Todd B Monroe; Adam Simning; Yeates Conwell; Thomas V Caprio; Xueya Cai; Helena Temkin-Greener; Ulrike Muench; Fang Yu; Song Ge; Yue Li Journal: Pain Manag Nurs Date: 2020-07-14 Impact factor: 1.929
Authors: Eric J Roseen; Iniya Rajendran; Peter Stein; Lisa Fredman; Howard A Fink; Michael P LaValley; Robert B Saper Journal: J Gen Intern Med Date: 2021-04-19 Impact factor: 6.473
Authors: Anders Nikolai Åsberg; Knut Hagen; Lars Jacob Stovner; Ingrid Heuch; John-Anker Zwart; Bendik Slagsvold Winsvold Journal: PLoS One Date: 2018-09-28 Impact factor: 3.240
Authors: Stefan Repky; Gisela Büchele; Klaus-Peter Günther; Klaus Huch; Hermann Brenner; Til Stürmer; Jan Beyersmann; Rolf E Brenner; Dietrich Rothenbacher Journal: Sci Rep Date: 2020-09-01 Impact factor: 4.379
Authors: Emma Fisher; Christopher Eccleston; Louisa Degenhardt; David P Finn; Nanna B Finnerup; Ian Gilron; Simon Haroutounian; Elliot Krane; Andrew S C Rice; Michael Rowbotham; Mark Wallace; R Andrew Moore Journal: Pain Rep Date: 2019-04-30